Multiple investment banks downgraded DraftKings' stock rating and reduced their price targets, citing market volatility and concerns over future spending and 2027 expectations. This widespread negative analyst sentiment is likely to exert downward pressure on DKNG's share price in the short term.
On November 9, 2026, DraftKings experienced a wave of negative analyst revisions. Stifel, UBS, and JPMorgan all downgraded the stock, while Truist and Macquarie lowered their price targets, albeit maintaining Buy/Outperform ratings. This collective shift in analyst sentiment, driven by concerns over 'prediction business spending and 2027 expectations,' signals a more cautious outlook for the company's future performance. For traders, this implies potential short-term selling pressure on DKNG shares as institutional investors may re-evaluate their positions. The key risk is further downside if these concerns materialize, while an opportunity could arise for long-term investors if the market overreacts and the company can address these spending and expectation issues effectively.